Medicare Drug Pricing Negotiations: Assessing Constitutional Structural Limits

Erica N. White; Mary Saxon; James G. Hodge; Joel Michaels

doi:10.1017/jme.2024.12

Medicare Drug Pricing Negotiations: Assessing Constitutional Structural Limits

Erica N. White, Mary Saxon, James G. Hodge, Joel Michaels

Law, Sandra Day O'Connor College of (LAW)

Research output: Contribution to journal › Article › peer-review

Abstract

A series of structural constitutional arguments lodged in multiple cases against Centers for Medicare and Medicaid Services' (CMS) authorities to negotiate prescription drug prices via the 2022 Inflation Reduction Act threaten the legitimacy of CMS program and federal agency powers.

Original language	English (US)
Pages (from-to)	956-960
Number of pages	5
Journal	Journal of Law, Medicine and Ethics
Volume	51
Issue number	4
DOIs	https://doi.org/10.1017/jme.2024.12
State	Published - Mar 13 2023

Keywords

Agency Deference
CMS
Constitution
Medicare
Prescription Drugs
Public Health

ASJC Scopus subject areas

General Medicine

Access to Document

10.1017/jme.2024.12

Cite this

@article{65303d6f665845de94d94ed1888f7a0c,

title = "Medicare Drug Pricing Negotiations: Assessing Constitutional Structural Limits",

abstract = "A series of structural constitutional arguments lodged in multiple cases against Centers for Medicare and Medicaid Services' (CMS) authorities to negotiate prescription drug prices via the 2022 Inflation Reduction Act threaten the legitimacy of CMS program and federal agency powers.",

keywords = "Agency Deference, CMS, Constitution, Medicare, Prescription Drugs, Public Health",

author = "White, {Erica N.} and Mary Saxon and Hodge, {James G.} and Joel Michaels",

note = "Publisher Copyright: {\textcopyright} The Author(s), 2024.",

year = "2023",

month = mar,

day = "13",

doi = "10.1017/jme.2024.12",

language = "English (US)",

volume = "51",

pages = "956--960",

journal = "Journal of Law, Medicine and Ethics",

issn = "1073-1105",

publisher = "Wiley-Blackwell",

number = "4",

}

TY - JOUR

T1 - Medicare Drug Pricing Negotiations

T2 - Assessing Constitutional Structural Limits

AU - White, Erica N.

AU - Saxon, Mary

AU - Hodge, James G.

AU - Michaels, Joel

N1 - Publisher Copyright: © The Author(s), 2024.

PY - 2023/3/13

Y1 - 2023/3/13

N2 - A series of structural constitutional arguments lodged in multiple cases against Centers for Medicare and Medicaid Services' (CMS) authorities to negotiate prescription drug prices via the 2022 Inflation Reduction Act threaten the legitimacy of CMS program and federal agency powers.

AB - A series of structural constitutional arguments lodged in multiple cases against Centers for Medicare and Medicaid Services' (CMS) authorities to negotiate prescription drug prices via the 2022 Inflation Reduction Act threaten the legitimacy of CMS program and federal agency powers.

KW - Agency Deference

KW - CMS

KW - Constitution

KW - Medicare

KW - Prescription Drugs

KW - Public Health

UR - http://www.scopus.com/inward/record.url?scp=85187787711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85187787711&partnerID=8YFLogxK

U2 - 10.1017/jme.2024.12

DO - 10.1017/jme.2024.12

M3 - Article

C2 - 38477275

AN - SCOPUS:85187787711

SN - 1073-1105

VL - 51

SP - 956

EP - 960

JO - Journal of Law, Medicine and Ethics

JF - Journal of Law, Medicine and Ethics

IS - 4

ER -

Medicare Drug Pricing Negotiations: Assessing Constitutional Structural Limits

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this